Matheus G, Chamoun M, Khosrotehrani K, Sivakumaran Y, Wells T
Burns Trauma. 2025; 13():tkae083.
PMID: 39830194
PMC: 11741523.
DOI: 10.1093/burnst/tkae083.
Abe R, Ram-Mohan N, Zudock E, Lewis S, Carroll K, Yang S
Front Immunol. 2024; 15:1457174.
PMID: 39359730
PMC: 11445025.
DOI: 10.3389/fimmu.2024.1457174.
Liu J, Lin X, Bai C, Soteyome T, Bai X, Wang J
Bioengineered. 2022; 13(5):12088-12098.
PMID: 35577356
PMC: 9275876.
DOI: 10.1080/21655979.2022.2072601.
Mueller-Ortiz S, Drouin S, Wetsel R
Infect Immun. 2004; 72(5):2899-906.
PMID: 15102802
PMC: 387850.
DOI: 10.1128/IAI.72.5.2899-2906.2004.
Miller R, Britigan B
Clin Microbiol Rev. 1997; 10(1):1-18.
PMID: 8993856
PMC: 172912.
DOI: 10.1128/CMR.10.1.1.
Efficacy of ceftazidime and aztreonam alone or in combination with amikacin in experimental left-sided Pseudomonas aeruginosa endocarditis.
Pefanis A, Giamarellou H, Karayiannakos P, Donta I
Antimicrob Agents Chemother. 1993; 37(2):308-13.
PMID: 8452362
PMC: 187658.
DOI: 10.1128/AAC.37.2.308.
Functional properties of isotype-switched immunoglobulin M (IgM) and IgG monoclonal antibodies to Pseudomonas aeruginosa lipopolysaccharide.
Pollack M, Koles N, Preston M, Brown B, Pier G
Infect Immun. 1995; 63(11):4481-8.
PMID: 7591089
PMC: 173638.
DOI: 10.1128/iai.63.11.4481-4488.1995.
Reduced resistance to Pseudomonas septicaemia in diabetic mice.
Kitahara Y, Ishibashi T, Harada Y, Takamoto M, Tanaka K
Clin Exp Immunol. 1981; 43(3):590-8.
PMID: 7026096
PMC: 1537194.
Influence of serum concentration on opsonization by the classical and alternative complement pathways.
Tofte R, Peterson P, Kim Y, Quie P
Infect Immun. 1980; 27(2):693-6.
PMID: 6991425
PMC: 550821.
DOI: 10.1128/iai.27.2.693-696.1980.
Opsonization and phagocytosis of mucoid and non-mucoid Pseudomonas aeruginosa strains.
Meshulam T, Verbrugh H, Verhoef J
Eur J Clin Microbiol. 1982; 1(2):112-7.
PMID: 6816585
DOI: 10.1007/BF02014202.
Serum-induced lysis of Pseudomonas aeruginosa.
Meshulam T, Verbrugh H, Verhoef J
Eur J Clin Microbiol. 1982; 1(1):1-6.
PMID: 6816583
DOI: 10.1007/BF02014132.
Safety and immunogenicity of high molecular weight polysaccharide vaccine from immunotype 1 Pseudomonas aeruginosa.
Pier G
J Clin Invest. 1982; 69(2):303-8.
PMID: 6799548
PMC: 370979.
DOI: 10.1172/jci110453.
Active immunization with lipopolysaccharide Pseudomonas antigen for chronic Pseudomonas bronchopneumonia in guinea pigs.
Pennington J, Hickey W, Blackwood L, Arnaut M
J Clin Invest. 1981; 68(5):1140-8.
PMID: 6795229
PMC: 370907.
DOI: 10.1172/jci110358.
Cystic fibrosis pseudomonas opsonins. Inhibitory nature in an in vitro phagocytic assay.
Fick Jr R, Naegel G, Matthay R, Reynolds H
J Clin Invest. 1981; 68(4):899-914.
PMID: 6793632
PMC: 370877.
DOI: 10.1172/jci110345.
Serum bactericidal effect on Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Thomassen M, Demko C
Infect Immun. 1981; 33(2):512-8.
PMID: 6792079
PMC: 350729.
DOI: 10.1128/iai.33.2.512-518.1981.
Genetics of serum resistance in Neisseria gonorrhoeae: the sac-1 genetic locus.
Cannon J, Lee T, Guymon L, Sparling P
Infect Immun. 1981; 32(2):547-52.
PMID: 6788697
PMC: 351481.
DOI: 10.1128/iai.32.2.547-552.1981.
Influence of anti-slime glycolipoprotein serum on the interaction between Pseudomonas aeruginosa and macrophages.
Bartell P, KRIKSZENS A
Infect Immun. 1980; 27(3):777-83.
PMID: 6769808
PMC: 550839.
DOI: 10.1128/iai.27.3.777-783.1980.
Protection against fatal Pseudomonas aeruginosa burn wound sepsis by immunization with lipopolysaccharide and high-molecular-weight polysaccharide.
Cryz Jr S, Furer E, Germanier R
Infect Immun. 1984; 43(3):795-9.
PMID: 6698608
PMC: 264250.
DOI: 10.1128/iai.43.3.795-799.1984.
The effect of C3 levels on yeast opsonization by normal and pathological sera: identification of a complement independent opsonin.
Kerr M, FALCONER J, Bashey A, BECK J
Clin Exp Immunol. 1983; 54(3):793-800.
PMID: 6652976
PMC: 1536141.
Passive protection against Pseudomonas aeruginosa infection in an experimental leukopenic mouse model.
Cryz Jr S, Furer E, Germanier R
Infect Immun. 1983; 40(2):659-64.
PMID: 6551339
PMC: 264905.
DOI: 10.1128/iai.40.2.659-664.1983.
